Cargando…
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
Non-small cell lung cancer (NSCLC) is one of the deadliest cancers worldwide. In search for new NSCLC treatment options, we screened a cationic amphiphilic drug (CAD) library for cytotoxicity against NSCLC cells and identified several CAD antihistamines as inducers of lysosomal cell death. We then p...
Autores principales: | Ellegaard, Anne-Marie, Dehlendorff, Christian, Vind, Anna C., Anand, Atul, Cederkvist, Luise, Petersen, Nikolaj H.T., Nylandsted, Jesper, Stenvang, Jan, Mellemgaard, Anders, Østerlind, Kell, Friis, Søren, Jäättelä, Marja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972561/ https://www.ncbi.nlm.nih.gov/pubmed/27333030 http://dx.doi.org/10.1016/j.ebiom.2016.06.013 |
Ejemplares similares
-
Cationic amphiphilic antihistamines inhibit STAT3 via Ca(2+)-dependent lysosomal H(+) efflux
por: Liu, Bin, et al.
Publicado: (2023) -
Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?
por: Gitahy Falcao Faria, Clara, et al.
Publicado: (2021) -
Identification of antiviral antihistamines for COVID-19 repurposing
por: Reznikov, Leah R., et al.
Publicado: (2021) -
Identification of Cytoskeleton-Associated Proteins Essential for Lysosomal Stability and Survival of Human Cancer Cells
por: Groth-Pedersen, Line, et al.
Publicado: (2012) -
Repurposing Cationic Amphiphilic Drugs and Derivatives to Engage Lysosomal Cell Death in Cancer Treatment
por: Hu, Michelle, et al.
Publicado: (2020)